DIN 02484218 — VYZULTA 0.024 %
VYZULTA is a solution of Latanoprostene bunod marketed by BAUSCH & LOMB INC. The full Latanoprostene bunod monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02484218
- Brand name
- VYZULTA
- Active ingredient
- Latanoprostene bunod
- Strength
- 0.024 %
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Manufacturer
- BAUSCH & LOMB INC
- Health Canada status
- MARKETED
- Drug class
- Prostaglandin F2α analogue / nitric oxide-donating intraocular pressure-lowering agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.